Author

Ruoxin Fang

Observed name: Ruo-Xin Fang

Institutions: Wuhan Union Hospital, Huazhong University of Science and Technology

Observed institutions: Zhongnan Hospital of Wuhan University, Wuhan Union Hospital, Huazhong University of Science and Technology

ORCID: 0000-0001-5395-3583

Observed ORCID: 0000-0001-5395-3583

OpenAlex ID: A5046656210

Abnormal lipid metabolism in cancer-associated cachexia and potential therapy strategy

2023 · Ruoxin Fang, Ling Yan, et al. · Frontiers in Oncology · 36

Artesunate induces ferroptosis in gastric cancer by targeting the TFRC-HSPA9 axis for iron homeostasis regulation

2025 · Yi Liu, You Yu, et al. · Redox Biology · 16

Unraveling the obesity paradox in small cell lung cancer immunotherapy: unveiling prognostic insights through body composition analysis

2024 · Ruoxin Fang, Ling Yan, et al. · Frontiers in Immunology · 10

Clinical Response of Advanced Lung Adenocarcinoma with Class III BRAF G466V Missense Mutation to Dabrafenib and Trametinib: A Case Report

2024 · Ruoxin Fang, Sha Xu, et al. · OncoTargets and Therapy · 3

Potential preventive effects of time-restricted eating on cancer

2023 · Ruo-Xin Fang, Ling Yan, et al. · journal of nutritional oncology · 3

An advanced pulmonary sarcomatoid carcinoma patient harboring a BRAFV600E mutation responds to dabrafenib and trametinib: a case report and literature review

2023 · Ruoxin Fang, Jun Gong, et al. · Frontiers in Oncology · 2

PFKFB4 Deubiquitination by USP10 Enhances Fumarate Metabolism to Orchestrate the KDM1A/Rad51 Axis and Confer Radioresistance in Lung Cancer

2026 · Yunshang Chen, Zilong Wu, et al. · Advanced Science

UBE2O Drives Immune Evasion and Radioimmunotherapy Resistance in Lung Cancer by Degrading CDKL1 to Induce PD‐L1 Transcription

2026 · Huichan Xue, Xiaohua Jie, et al. · Advanced Science

Works count: 8

Citation count: 70

H-index: 3

I10-index: 3